近岸蛋白
(688137)
| 流通市值：11.92亿 | | | 总市值：25.60亿 |
| 流通股本：3267.54万 | | | 总股本：7017.54万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 668,950,856.76 | 1,131,075,224.33 | 1,393,411,953.22 | 863,702,581.67 |
| 应收票据及应收账款 | 62,733,487.23 | 58,400,195.18 | 59,400,401.26 | 67,351,164.26 |
| 其中：应收票据 | - | - | 400,000 | 400,000 |
| 应收账款 | 62,733,487.23 | 58,400,195.18 | 59,000,401.26 | 66,951,164.26 |
| 应收款项融资 | - | 325,250 | 11,440,000 | 12,620,000 |
| 预付款项 | 5,286,674.7 | 5,585,352.47 | 7,459,125.3 | 5,224,823.05 |
| 其他应收款合计 | 4,909,306.69 | 5,146,274.54 | 5,259,392.18 | 3,726,157.34 |
| 存货 | 80,153,890.81 | 78,702,688.7 | 86,593,778.38 | 84,967,345.51 |
| 其他流动资产 | 1,147,893,565.16 | 767,571,417.23 | 501,317,775.97 | 410,908,059.61 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,969,927,781.35 | 2,046,806,402.45 | 2,064,882,426.31 | 2,070,205,057.6 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,000,000 | - | - | - |
| 固定资产 | 41,865,582.31 | 44,444,386.97 | 35,605,398.68 | 37,242,391.6 |
| 在建工程 | 53,812,936.04 | 36,473,932.84 | 41,331,784.55 | 31,264,393.64 |
| 使用权资产 | 65,896,219 | 70,735,248.62 | 75,387,750.75 | 65,417,710.83 |
| 无形资产 | 18,336,719.87 | 18,463,682.42 | 18,590,644.97 | 18,714,245.68 |
| 长期待摊费用 | 14,250,448.95 | 15,059,940.71 | 15,435,690.94 | 9,686,386.15 |
| 递延所得税资产 | 41,575,695.29 | 37,009,901.43 | 31,722,544.06 | 27,939,312.39 |
| 其他非流动资产 | 27,924,987.55 | 27,255,889.54 | 27,169,774.72 | 38,445,722.47 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 273,662,589.01 | 249,442,982.53 | 245,243,588.67 | 228,710,162.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,243,590,370.36 | 2,296,249,384.98 | 2,310,126,014.98 | 2,298,915,220.36 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 19,268,329.1 | 16,756,077 | 21,472,899.3 | 17,936,273.71 |
| 应付账款 | 19,268,329.1 | 16,756,077 | 21,472,899.3 | 17,936,273.71 |
| 合同负债 | 5,140,370 | 4,645,694.38 | 4,415,657.76 | 4,186,715.01 |
| 应付职工薪酬 | 7,485,431.72 | 7,390,039.41 | 7,771,054.15 | 8,726,504.27 |
| 应交税费 | 1,386,492.39 | 1,227,979.82 | 2,583,503.37 | 4,314,901.1 |
| 其他应付款合计 | 552,425.2 | 35,503,218.58 | 737,639.83 | 829,482.34 |
| 应付股利 | - | 35,087,719.5 | - | - |
| 一年内到期的非流动负债 | 18,114,873.02 | 17,687,365.85 | 17,872,103.74 | 11,078,317.44 |
| 其他流动负债 | 2,669,195.83 | 2,978,276.86 | 2,500,822.78 | 3,049,408.13 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 54,617,117.26 | 86,188,651.9 | 57,353,680.93 | 50,121,602 |
| 非流动负债: | | | | |
| 租赁负债 | 53,227,314.61 | 57,945,468.2 | 62,294,632.14 | 59,435,407.39 |
| 递延收益 | 938,283.17 | 960,457.94 | 1,410,122.44 | 868,712.92 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 54,165,597.78 | 58,905,926.14 | 63,704,754.58 | 60,304,120.31 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 108,782,715.04 | 145,094,578.04 | 121,058,435.51 | 110,425,722.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 70,175,439 | 70,175,439 | 70,175,439 | 70,175,439 |
| 资本公积 | 1,960,281,639.86 | 1,956,937,664.89 | 1,953,502,514.38 | 1,950,276,774.5 |
| 减:库存股 | 10,346,681.91 | - | - | - |
| 其他综合收益 | 182,763 | 174,466.36 | 159,350.81 | 176,534.59 |
| 盈余公积 | 18,341,366.76 | 18,341,366.76 | 18,341,366.76 | 18,341,366.76 |
| 未分配利润 | 96,173,128.61 | 105,525,869.93 | 146,888,908.52 | 149,519,383.2 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,134,807,655.32 | 2,151,154,806.94 | 2,189,067,579.47 | 2,188,489,498.05 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,134,807,655.32 | 2,151,154,806.94 | 2,189,067,579.47 | 2,188,489,498.05 |
| 负债和股东权益合计 | 2,243,590,370.36 | 2,296,249,384.98 | 2,310,126,014.98 | 2,298,915,220.36 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |